USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Illumina Cambridge Limited

USPTO PatentsView assignee record - 253 granted patents across 42 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

RSS updates for this company

The verdict

According to USPTO PatentsView, Illumina ranks #1,629 of 49,997 tracked US assignees by granted-patent volume, with 253 patents across 42 technology areas.

#1,629
of 49,997 US assignees by volume
Top 3%
by Innovation Score (62.0/100)
19.3
avg claims per patent
+57%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1629 · Foreign Corporation #1,629 · 253 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MID 253 grants
  • TOP-DECILE #1,629/49,997
  • PHOTO-FINISH Aruba Networks
  • CPC-WIDE C12Q · 42 areas
  • INNOV-STRONG 62.0/100
  • CLAIMS-RICH 19.3 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +57% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Aruba Networks, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Illumina

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Illumina's Innovation Score is 62.0/100 (top 3% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Illumina's grants concentrate

Illumina Cambridge Limited is a focused PatentsView assignee: 42 CPC subclasses with 83.8% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2024 (34 grants) versus a trough of 10 in 2017. By volume, Illumina sits between Aruba Networks, Inc. and Garrett Transportation I Inc..

Illumina's three-year grant acceleration

From 2019–2021 to 2022–2024, Illumina Cambridge Limited moved from 75 to 94 grants (1.25x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #703. See the growth leaderboard.

Who files at Illumina's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Illumina holds 253 patents at rank #1,629, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Illumina

By rank, the assignees closest to #1,629 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Illumina's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Illumina, neither rank-band nor same-CPC leaders (those blocks stay above).

Illumina's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

62 Top 3% higher than 97% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

010203040 20152016201720182019202020212022202320242025 17
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Illumina Cambridge Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 15 5.9%
2016 18 7.1%
2017 10 4.0%
2018 24 9.5%
2019 25 9.9%
2020 19 7.5%
2021 31 12.3%
2022 28 11.1%
2023 32 12.6%
2024 34 13.4%
2025partial year 17 6.7%

Which technologies does Illumina Cambridge Limited patent most?

Top 15 of 42 technology areas

Where it ranks

Overall rank by patents

#1,629

of 49,997 tracked assignees

Innovation Score

62.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Illumina Cambridge Limited's patent record in context - here's where to go next.

  • Illumina Cambridge Limited's lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 83.8% of its portfolio - see every assignee active in that class. Explore C12Q
  • Ranked #1,629 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Illumina Cambridge Limited against Aruba Networks, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 62.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.